This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Persistent left superior vena cava Persistent Left Superior Vena Cava


1. History

Persistent left superior vena cava (PLSVC) is an anatomical variant that occurs when the embryonic left anterior cardinal vein does not disappear normally and persists. Normally, this vessel regresses at around 8–10 weeks of gestation, leaving only the left brachiocephalic vein and the ligament of Marshall.

Arantius first described this structure in 1707, and in the early 20th century it was known only from anatomical observation. Its clinical importance emerged with advances in cardiac surgery, pacemaker implantation, and central venous catheter (CVC) insertion. Cases in which PLSVC was discovered incidentally when central venous catheters or pacemaker leads were inserted via an abnormal route (left subclavian vein → PLSVC → coronary sinus → right atrium) increased.

Recently, as it has become known that the presence of PLSVC affects the procedural route when approaching via the coronary sinus during catheter ablation for atrial fibrillation, it has also drawn attention in the field of cardiac electrophysiology. PLSVC is mostly clinically asymptomatic, but correction may be needed in complex congenital heart malformations with coronary sinus dilation.

2. Causes

PLSVC occurs when normal regression does not take place during fetal cardiovascular development.

In normal development, the left anterior cardinal vein gradually regresses at around 8–10 weeks of gestation, and its residual structure, the left brachiocephalic vein, forms and connects left head and neck venous flow to the right superior vena cava. If this regression fails, the left anterior cardinal vein persists, forming the PLSVC.

When a PLSVC forms, blood from the left head and neck veins (left subclavian vein, left internal jugular vein) flows via the left-sided route (PLSVC) into the coronary sinus and returns to the right atrium. Cases are divided into those in which the normal right superior vena cava is present (~80%) and those in which it is absent (~20%).

No specific genetic variant for its cause has been identified, but because it often appears together with complex congenital heart malformations (especially heterotaxy syndrome, polysplenia), abnormalities in genes related to cardiovascular development are presumed to be indirectly involved. It also occurs sporadically.

3. Genetics

PLSVC mostly occurs as an isolated variant, sporadically and without a specific genetic cause.

Association with heterotaxy syndrome (Heterotaxy/Situs ambiguus):

22q11.2 deletion syndrome:

Isolated PLSVC:

When PLSVC exists in isolation, the clinical need for genetic testing is low. However, when complex congenital heart malformations are present, a comprehensive genetic evaluation is performed.

4. General epidemiology

PLSVC is relatively common among congenital vascular variants.

There is no or minimal sex difference. Large-scale data on racial differences are lacking.

Classified according to the presence or absence of an accompanying right superior vena cava:

PLSVC is mostly discovered incidentally. The most common scenario is discovery when, during central venous catheter insertion via the left subclavian vein, the catheter enters an abnormal route (→ coronary sinus → right atrium). It is also discovered incidentally during pacemaker lead insertion, preoperative cardiac CT, transthoracic echocardiography, etc.

5. Pathophysiology

The pathophysiology of PLSVC varies according to the anatomical connection.

Typical connection (PLSVC → coronary sinus → right atrium, venous blood):

Atypical connection (PLSVC → left atrium, with intracardiac defect):

Association with coronary sinus defects:

Studies have also reported that in atrial fibrillation, the PLSVC can be the origin of an ectopic focus.

6. Symptoms

The symptoms of PLSVC vary greatly depending on the type of connection and accompanying malformations.

Typical connection (→ coronary sinus → right atrium):

Atypical connection (→ left atrium, with unroofed coronary sinus):

Symptoms related to accompanying cardiac malformations:

Even without clinical symptoms, identifying the presence of a PLSVC before procedures such as surgery, pacemaker implantation, or catheter ablation is important for procedural planning.

7. Signs

Physical examination findings:

A PLSVC with a typical connection does not by itself show specific physical examination findings. Diagnosis is made mainly on imaging studies.

Echocardiography findings:

Chest CT/MRA findings:

Incidental discovery on central venous catheterization:

8. Screening

Because PLSVC is mostly asymptomatic, there is no specific screening program. However, it is important to actively check for PLSVC in the following situations:

Evaluation of the coronary sinus when performing echocardiography:

Confirmation before procedures:

Before catheter ablation for atrial fibrillation:

When evaluating complex congenital heart malformations:

9. Diagnosis

Tests used to diagnose PLSVC:

Echocardiography:

Cardiovascular CT angiography (CTA) or MRA:

Venography:

Chest X-ray:

10. Treatment

The treatment approach for PLSVC is determined by the type of connection and accompanying malformations.

Typical connection (→ coronary sinus → right atrium): no treatment needed

Atypical connection (PLSVC → left atrium, with unroofed coronary sinus): correction needed

Treatment of accompanying congenital heart malformations:

Caution during pacemaker/ICD implantation:

11. Prognosis

The prognosis of PLSVC varies according to the type of connection and accompanying malformations.

Isolated PLSVC with typical connection:

Atypical connection or accompanying unroofed coronary sinus:

Accompanying complex congenital heart malformations:

Atrial arrhythmias:

12. Prevention

There is no way to prevent the occurrence of PLSVC itself. Clinically, preventing complications caused by PLSVC is important.

Prevention of procedure-related complications:

Prevention of complications of atypical connections:

Regular follow-up:

Genetic counseling: when complex congenital heart malformations are present, family risk is assessed as part of genetic counseling for those malformations.

13. References

  1. Biffi M, et al. Left superior vena cava persistence in patients undergoing cardiac implantable device implantation: a multicenter study. Europace. 2009;11(9):1177-1183. PMID:19620145
  2. Nsah EN, et al. Persistent left superior vena cava in patients with normal and congenitally abnormal hearts. Clin Cardiol. 1991;14(8):678-682. PMID:1831299
  3. Johansson M, et al. Echocardiographic evaluation of the right heart. J Am Soc Echocardiogr. 2010;23(7):685-713. PMID:20620805
  4. Peltier M, et al. Persistent left superior vena cava associated with coronary sinus dilatation on echocardiography. Eur J Echocardiogr. 2006;7(6):508-510. PMID:16443403
  5. Tak T, et al. Persistent left superior vena cava: clinical implications and management. Int J Angiol. 2002;11(3):131-133. DOI:10.1007/BF01616108
  6. Sarodia BD, Stoller JK. Persistent left superior vena cava: case report and literature review. Respir Care. 2000;45(4):411-416. PMID:10771471
  7. Ratliff HL, et al. Left superior vena cava: review of the literature, clinical implications, and relevance to the electrophysiologist. Pacing Clin Electrophysiol. 2006;29(9):1010-1016. PMID:16981658
  8. Campbell M, Deuchar DC. The left-sided superior vena cava. Br Heart J. 1954;16(4):423-439. PMID:13199660
  9. Goyal SK, et al. Persistent left superior vena cava: a case report and review of literature. Cardiovasc Ultrasound. 2008;6:50. PMID:18939983
  10. Albay S, et al. Persistent left superior vena cava detected during routine dissection in anatomy class. Folia Morphol (Warsz). 2006;65(1):68-70. PMID:16783718